The National Pharmaceutical Pricing Authority (NPPA), on November 2, 2026, has amended its notification S.O. 5638(E) dated November 2, 2018, relating to the fixation of retail prices of formulations.
The corrigendum revises the entry at Serial No. 35 to specify the formulation Diclofenac + Methyl Salicylate + Menthol Gel, containing Diclofenac Diethylamine BP 2.32% w/w (equivalent to Diclofenac Sodium 2% w/w), Methyl Salicylate IP 10% w/w and Menthol IP 5% w/w, at a retail price of ₹6.25 per gram, manufactured and marketed by M/s Sun Pharmaceutical Industries Ltd. Further, entries at Serial Nos. 36, 51 and 52 of the original notification stand deleted. All notes and other contents of the original order relating to Serial No. 35 remain unchanged.
The corrigendum amends the existing retail price fixation notification and requires the concerned manufacturer and marketing company to adhere to the revised entry and applicable conditions of the original order.
[NPPA Corrigendum S.O. 6002(E)]
